|
US5087240A
(en)
|
1983-08-18 |
1992-02-11 |
Drug Delivery Systems Inc. |
Transdermal drug patch with conductive fibers
|
|
US4921475A
(en)
|
1983-08-18 |
1990-05-01 |
Drug Delivery Systems Inc. |
Transdermal drug patch with microtubes
|
|
US4738851A
(en)
|
1985-09-27 |
1988-04-19 |
University Of Iowa Research Foundation, Inc. |
Controlled release ophthalmic gel formulation
|
|
US5163899A
(en)
|
1987-03-20 |
1992-11-17 |
Drug Delivery Systems Inc. |
Transdermal drug delivery system
|
|
US5312325A
(en)
|
1987-05-28 |
1994-05-17 |
Drug Delivery Systems Inc |
Pulsating transdermal drug delivery system
|
|
GB8804164D0
(en)
|
1988-02-23 |
1988-03-23 |
Tucker J M |
Bandage for administering physiologically active compound
|
|
US4882150A
(en)
|
1988-06-03 |
1989-11-21 |
Kaufman Herbert E |
Drug delivery system
|
|
US5008110A
(en)
|
1988-11-10 |
1991-04-16 |
The Procter & Gamble Company |
Storage-stable transdermal patch
|
|
US5088977A
(en)
|
1988-12-21 |
1992-02-18 |
Drug Delivery Systems Inc. |
Electrical transdermal drug applicator with counteractor and method of drug delivery
|
|
JPH05501505A
(ja)
|
1989-04-28 |
1993-03-25 |
ライカー ラボラトリーズ，インコーポレイティド |
乾燥粉末吸入装置
|
|
US5521222A
(en)
|
1989-09-28 |
1996-05-28 |
Alcon Laboratories, Inc. |
Topical ophthalmic pharmaceutical vehicles
|
|
CA2031376A1
(en)
|
1989-12-04 |
1991-06-05 |
Bahram Farhadieh |
Single layer transdermal drug administration system
|
|
US5364833A
(en)
|
1990-05-09 |
1994-11-15 |
Basf Aktiengesellschaft |
Cyclohexenone oxime ethers, their preparation and their use as herbicides
|
|
US5077033A
(en)
|
1990-08-07 |
1991-12-31 |
Mediventures Inc. |
Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
|
|
DK0495421T3
(da)
|
1991-01-15 |
1996-12-09 |
Alcon Lab Inc |
Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
|
|
US5404871A
(en)
|
1991-03-05 |
1995-04-11 |
Aradigm |
Delivery of aerosol medications for inspiration
|
|
US6060069A
(en)
|
1991-05-20 |
2000-05-09 |
Dura Pharmaceuticals, Inc. |
Pulmonary delivery of pharmaceuticals
|
|
US5327883A
(en)
|
1991-05-20 |
1994-07-12 |
Dura Pharmaceuticals, Inc. |
Apparatus for aerosolizing powdered medicine and process and using
|
|
US5492112A
(en)
|
1991-05-20 |
1996-02-20 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
|
US5352456A
(en)
|
1991-10-10 |
1994-10-04 |
Cygnus Therapeutic Systems |
Device for administering drug transdermally which provides an initial pulse of drug
|
|
IL104068A
(en)
|
1991-12-12 |
1998-10-30 |
Glaxo Group Ltd |
Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
|
|
CA2123809A1
(en)
|
1991-12-18 |
1993-06-24 |
Debra L. Wilfong |
Multilayered barrier structures
|
|
US5320094A
(en)
|
1992-01-10 |
1994-06-14 |
The Johns Hopkins University |
Method of administering insulin
|
|
ATE132381T1
(de)
|
1992-01-29 |
1996-01-15 |
Voelkl Franz Ski |
Ballspielschläger, insbesondere tennisschläger
|
|
US5277195A
(en)
|
1992-02-03 |
1994-01-11 |
Dura Pharmaceuticals, Inc. |
Portable spirometer
|
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
|
DE69322789T2
(de)
|
1992-10-19 |
1999-07-01 |
Dura Pharmaceuticals, Inc., San Diego, Calif. |
Trockenpulverinhalator
|
|
US5672581A
(en)
|
1993-01-29 |
1997-09-30 |
Aradigm Corporation |
Method of administration of insulin
|
|
US6131567A
(en)
|
1993-01-29 |
2000-10-17 |
Aradigm Corporation |
Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
|
|
ES2154673T3
(es)
|
1993-01-29 |
2001-04-16 |
Aradigm Corp |
Suministro intrapulmonar de hormonas.
|
|
US5364838A
(en)
|
1993-01-29 |
1994-11-15 |
Miris Medical Corporation |
Method of administration of insulin
|
|
US5743250A
(en)
|
1993-01-29 |
1998-04-28 |
Aradigm Corporation |
Insulin delivery enhanced by coached breathing
|
|
US5558085A
(en)
|
1993-01-29 |
1996-09-24 |
Aradigm Corporation |
Intrapulmonary delivery of peptide drugs
|
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
|
US5506203C1
(en)
|
1993-06-24 |
2001-02-06 |
Astra Ab |
Systemic administration of a therapeutic preparation
|
|
US5661130A
(en)
|
1993-06-24 |
1997-08-26 |
The Uab Research Foundation |
Absorption enhancers for drug administration
|
|
DE69535897D1
(de)
|
1994-03-07 |
2009-01-22 |
Nektar Therapeutics |
Verfahren und Zusammensetzung für die pulmonale Darreichung von Insulin
|
|
IL114193A
(en)
|
1994-06-20 |
2000-02-29 |
Teva Pharma |
Ophthalmic pharmaceutical compositions based on sodium alginate
|
|
ES2094688B1
(es)
|
1994-08-08 |
1997-08-01 |
Cusi Lab |
Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
|
|
US5780014A
(en)
|
1995-04-14 |
1998-07-14 |
Inhale Therapeutic Systems |
Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
|
|
US5645051A
(en)
|
1995-04-21 |
1997-07-08 |
Dura Pharmaceuticals, Inc. |
Unit dose dry powder inhaler
|
|
US5622166A
(en)
|
1995-04-24 |
1997-04-22 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler delivery system
|
|
US5700904A
(en)
|
1995-06-07 |
1997-12-23 |
Eli Lilly And Company |
Preparation of an acylated protein powder
|
|
US5654007A
(en)
|
1995-06-07 |
1997-08-05 |
Inhale Therapeutic Systems |
Methods and system for processing dispersible fine powders
|
|
IT1283911B1
(it)
|
1996-02-05 |
1998-05-07 |
Farmigea Spa |
Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
|
|
US5800807A
(en)
|
1997-01-29 |
1998-09-01 |
Bausch & Lomb Incorporated |
Ophthalmic compositions including glycerin and propylene glycol
|
|
ZA989744B
(en)
|
1997-10-31 |
2000-04-26 |
Lilly Co Eli |
Method for administering acylated insulin.
|
|
US6261547B1
(en)
|
1998-04-07 |
2001-07-17 |
Alcon Manufacturing, Ltd. |
Gelling ophthalmic compositions containing xanthan gum
|
|
US6197934B1
(en)
|
1998-05-22 |
2001-03-06 |
Collagenesis, Inc. |
Compound delivery using rapidly dissolving collagen film
|
|
US6241969B1
(en)
|
1998-06-26 |
2001-06-05 |
Elan Corporation Plc |
Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
|
|
US20020006901A1
(en)
|
1999-02-05 |
2002-01-17 |
Aldo T. Iacono |
Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
|
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
|
WO2001051030A1
(en)
|
2000-01-10 |
2001-07-19 |
Dura Pharmaceuticals, Inc. |
Pharmaceutical formulation and method for pulmonary and oral delivery
|
|
AU2003287965A1
(en)
|
2002-10-24 |
2004-05-13 |
Carex Sa |
Modulation of peroxisome proliferator activated receptors activity
|
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
|
EP1836188A1
(en)
|
2004-12-30 |
2007-09-26 |
Astex Therapeutics Limited |
Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
|
|
WO2006070202A1
(en)
|
2004-12-30 |
2006-07-06 |
Astex Therapeutics Limited |
Pyrazole derivatives having kinase modulating activity
|
|
SI2206707T1
(sl)
|
2007-10-24 |
2014-11-28 |
Astellas Pharma Inc. |
Azolkarboksamidna spojina ali njena sol
|
|
EP2070925A1
(de)
|
2007-12-10 |
2009-06-17 |
Bayer Schering Pharma Aktiengesellschaft |
Neue 2-substituierte Tiazol-4-carbonsäureamid-Derivative deren Herstellung und Verwendung als Arzneimittel
|
|
US8987309B2
(en)
|
2009-04-17 |
2015-03-24 |
The Translational Genomics Research Institute |
Compounds, pharmaceutical compositions and methods of use of 2-aryl pyridylazoles
|
|
EP2243481A1
(en)
|
2009-04-24 |
2010-10-27 |
PamGene B.V. |
Irak kinase family as novel drug target for Alzheimer
|
|
JP2012254939A
(ja)
|
2009-10-07 |
2012-12-27 |
Astellas Pharma Inc |
オキサゾール化合物
|
|
CA2794801C
(en)
|
2010-04-07 |
2019-01-15 |
F. Hoffmann-La Roche Ag |
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
|
|
RU2632900C2
(ru)
|
2010-11-19 |
2017-10-11 |
Лиганд Фармасьютикалс Инкорпорейтед |
Гетероциклические амины и их применение
|
|
WO2012072685A1
(en)
|
2010-12-02 |
2012-06-07 |
Katholieke Universiteit Leuven, K.U.Leuven R&D |
Irak-related interventions and diagnosis
|
|
HUE029617T2
(en)
|
2010-12-20 |
2017-03-28 |
Merck Serono Sa |
Indazolyl triazole derivatives as IRAK inhibitors
|
|
EP3239154A1
(en)
|
2011-01-10 |
2017-11-01 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
|
CN103347873A
(zh)
|
2011-02-09 |
2013-10-09 |
日产化学工业株式会社 |
吡唑衍生物和有害生物防除剂
|
|
US8575336B2
(en)
|
2011-07-27 |
2013-11-05 |
Pfizer Limited |
Indazoles
|
|
WO2013042137A1
(en)
|
2011-09-19 |
2013-03-28 |
Aurigene Discovery Technologies Limited |
Bicyclic heterocycles as irak4 inhibitors
|
|
EP2760857A1
(en)
|
2011-09-27 |
2014-08-06 |
F.Hoffmann-La Roche Ag |
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
|
|
TW201728592A
(zh)
|
2012-01-10 |
2017-08-16 |
林伯士艾瑞斯公司 |
Ｉｒａｋ抑制劑及其用途
|
|
WO2014048939A1
(en)
|
2012-09-26 |
2014-04-03 |
F. Hoffmann-La Roche Ag |
Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
|
|
WO2014058691A1
(en)
|
2012-10-08 |
2014-04-17 |
Merck Sharp & Dohme Corp. |
Inhibitors of irak4 activity
|
|
WO2014110114A1
(en)
|
2013-01-10 |
2014-07-17 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
|
ES2639717T3
(es)
|
2013-02-07 |
2017-10-30 |
Merck Patent Gmbh |
Derivados de piridazinona macrocíclicos
|
|
JP6483624B2
(ja)
|
2013-02-07 |
2019-03-13 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ |
ピリダジノン−アミド誘導体
|
|
EP3049086A4
(en)
|
2013-09-27 |
2017-02-22 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
|
AU2014347027A1
(en)
|
2013-11-06 |
2016-06-23 |
Bristol-Myers Squibb Company |
GSK -3 inhibitors
|
|
CA2929316C
(en)
|
2013-11-08 |
2021-12-28 |
Takeda Pharmaceutical Company Limited |
Pyrazole for the treatment autoimmune disorders
|
|
EP3079682A4
(en)
|
2013-12-13 |
2017-08-30 |
Dana-Farber Cancer Institute, Inc. |
Methods to treat lymphoplasmacytic lymphoma
|
|
TWI667233B
(zh)
|
2013-12-19 |
2019-08-01 |
德商拜耳製藥公司 |
新穎吲唑羧醯胺，其製備方法、含彼等之醫藥製劑及其製造醫藥之用途
|
|
ES2728403T3
(es)
|
2014-01-09 |
2019-10-24 |
Merck Patent Gmbh |
Derivados de pirimidin pirazolilo y su uso como inhibidores de IRAK
|
|
HK1231480A1
(zh)
|
2014-01-10 |
2017-12-22 |
Aurigene Discovery Technologies Limited |
作为irak4抑制剂的吲唑化合物
|
|
IL311677B2
(en)
|
2014-01-13 |
2025-06-01 |
Aurigene Oncology Ltd |
Bicyclic heterocyclyl derivatives as irak4 inhibitors
|
|
LT3221306T
(lt)
|
2014-11-20 |
2020-03-10 |
Merck Patent Gmbh |
Heteroarilo junginiai, kaip irak inhibitoriai ir jų panaudojimas
|
|
DK3286181T3
(da)
|
2015-04-22 |
2021-04-06 |
Rigel Pharmaceuticals Inc |
Pyrazolforbindelser og fremgangsmåde til fremstilling og anvendelse af forbindelserne
|
|
CA2992406A1
(en)
|
2015-07-15 |
2017-01-19 |
Aurigene Discovery Technologies Limited |
Indazole and azaindazole compounds as irak-4 inhibitors
|
|
HK1256242A1
(zh)
|
2015-08-04 |
2019-09-20 |
Rigel Pharmaceuticals, Inc. |
吲哚化合物以及制备和使用该化合物的方法
|
|
CN110099899B
(zh)
|
2016-10-26 |
2024-01-02 |
里格尔药品股份有限公司 |
用作irak抑制剂的噁唑衍生物及其制备方法
|
|
CN110234637B
(zh)
|
2016-10-26 |
2022-11-01 |
里格尔药品股份有限公司 |
用作irak抑制剂的吡唑酰胺化合物
|
|
JP7167069B2
(ja)
|
2017-06-29 |
2022-11-08 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
キナーゼ阻害剤ならびに作製および使用のための方法
|
|
JP2022545542A
(ja)
|
2019-08-30 |
2022-10-27 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
ピラゾール化合物、その製剤並びに化合物及び／又は製剤を使用する方法
|